SillaJen Inc
KOSDAQ:215600
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cho Lon Real Estate JSC
VN:RCL
|
VN |
|
A
|
Action Electronics Co Ltd
TWSE:3024
|
TW |
|
N
|
Nitin Spinners Ltd
NSE:NITINSPIN
|
IN |
SillaJen Inc
Inventory
SillaJen Inc
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
SillaJen Inc
KOSDAQ:215600
|
Inventory
₩1.6B
|
CAGR 3-Years
14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Celltrion Inc
KRX:068270
|
Inventory
₩2.8T
|
CAGR 3-Years
66%
|
CAGR 5-Years
49%
|
CAGR 10-Years
28%
|
|
|
O
|
OliX Pharmaceuticals Inc
KOSDAQ:226950
|
Inventory
₩396.7m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Inventory
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Inventory
₩6.7B
|
CAGR 3-Years
49%
|
CAGR 5-Years
64%
|
CAGR 10-Years
N/A
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Inventory
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
SillaJen Inc
Glance View
SillaJen, Inc. develops oncolytic immunotherapeutics virus. The company is headquartered in Seoul, Seoul. The company went IPO on 2016-12-06. The Company’s major product is Pexa-Vec, which is in a global Phase 3 clinical trial that is used for the treatment of liver cancer. Additionally, it also offers oncolytic virus immunotherapeutics, including SJ-102, SJ-103, SJ-815, JX-929, JX-930, JX-963, JX-970 and others.970 and others.
See Also
What is SillaJen Inc's Inventory?
Inventory
1.6B
KRW
Based on the financial report for Sep 30, 2025, SillaJen Inc's Inventory amounts to 1.6B KRW.
What is SillaJen Inc's Inventory growth rate?
Inventory CAGR 3Y
14%
Over the last year, the Inventory growth was 3%. The average annual Inventory growth rates for SillaJen Inc have been 14% over the past three years .
